22.01.2010 • News

DSM invests in Bioprocess Control

DSM Venturing, the corporate venturing unit of Royal DSM, has announced that it has made an equity investment in Bioprocess Control, a market leader in providing advanced control technologies and services that enable the efficient design and optimal operation of biogas processes. In addition to the investment, a strategic cooperation agreement has been signed which will enable DSM and Bioprocess Control to leverage their complementary activities in the area of biogas. Financial details will not be disclosed.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read